Beat and hedged: why Aditya's guiding margins down despite the blowout
Q2 revenue jumped 89.9% YoY and management raised full-year guidance, but the real story is margin discipline and controlled H2 slowdown. The street has already priced in the beat; what matters now is whether management delivers on the margin hedge.
₹185.5 Cr
+165.1% YoY
₹34.4 Cr
one-time charge
₹220 Cr
+214% YoY · 12.6% margin
17.6%
vs 14–15% FY27 guided
The 185.5 crore PAT looks like a blowout, but a ₹34.4 crore loss from the Kadapa plant fire (September 2026, fully insured) masks the organic story. Pre-exceptional profit was ₹220 crore — a robust 12.6% margin that validates underlying momentum. The real tension is not whether Aditya beat; it's what management is choosing to do with that beat.
What the quarter actually delivered
Revenue ₹1,746 crore (+89.9% YoY, +24.5% QoQ) and EBITDA ₹307 crore at 17.6% margin are both ahead of the 14–15% EBITDA guidance management reaffirmed on the call. H1 combined revenue ₹3,148 crore (+89.7%) reflects sustained momentum, with Q2 carrying 55% of the half-year load. Market share rose to 42% (from 30% at IPO), anchored by CP PLUS IP products now representing 79% of the portfolio (vs. 71% prior year), the highest-margin segment.
Q2 revenue ₹1,746 Cr, up 89.9% YoY
Confirmed. H1 ₹3,148 Cr (+89.7%), market share 42% of ~₹7.5 Cr addressable market.
Supported
EBITDA margin 14–15% for FY27
H1 delivered 16.3%, Q2 delivered 17.6%, but management hedging H2 to ~13% due to SOC/memory cost volatility.
Supported but strategic
Revenue guidance raised to ₹6.5–6.8 Cr
Confirmed, raised from ₹6.0–6.5 Cr. H1 delivery of ₹3,148 Cr supports upper end of new range.
Supported
Market share 43–45% by FY27 end
At 42% now; three-tier brand strategy (CP PLUS Pro, NEXIVUE, EYRA) targets unorganized segment.
Credible
PAT margin raised to 9–10% for FY27
H1 delivered 11.5%. Post-QIP debt repayment lowers finance cost 41% YoY.
Supported
What changed on this call
Revenue guidance
Strong H1 momentum and market share gains justify upgrade. Growth accelerating.
Raised ₹6.0–6.5 Cr → ₹6.5–6.8 Cr
EBITDA margin guidance
Deliberate caution. Management prioritizing market share over margin expansion; H2 compression anticipated (~13%).
Maintained 14–15% despite H1 delivery of 16.3%
PAT margin guidance
Reflects pricing discipline and lower finance cost post-debt repayment.
Raised to 9–10% (from prior implied ~8%)
Market share target
Not new, but narrowed range signals high confidence. Implies 100–300 bps gain from 42% now.
Quantified and firmed at 43–45% by FY27 end
CapEx approval
Kadapa phase 3 + Greater Noida + backward integration plants. Housing trials Q4, commercial Q1 FY28.
₹650 Cr over 2–3 years for capacity doubling
The street's view — and where the stock sits
At ₹4,209 (as of Nov 12), Aditya trades 8.87% below its all-time high of ₹4,618.8 and well above its 52-week low of ₹1,348.3. The stock rallied sharply post-result on the beat and raised guidance, then cooled as the market digested the H2 margin hedge (implied ~13% EBITDA vs. H1 16.3%). Bulk deals on Nov 11 show mutual funds (Motilal Oswal, Kotak) accumulating (~₹582 Cr notional combined), but electronics company Dixon selling (~₹291 Cr), suggesting mixed sentiment near the highs. FII ownership ticked up to 6.35% (from 5.72%), but remains modest; DII at 13.61% and promoter holding 74.71%. The takeaway: the beat is real and widely credited, but the margin compression story is now the focus.
Q2 beat: revenue +89.9% YoY, EBITDA margin 17.6%
FY27 revenue guidance raised ₹6.0–6.5 Cr → ₹6.5–6.8 Cr (54–61% growth)
Market share momentum: 30% at IPO → 42% now → 45% target by FY27 end
Debt-free balance sheet post-QIP; finance cost down 41% YoY
Capacity doubling plan funded and on track (housing plant Q4 trials → Q1 FY28 commercial)
Only fully STOC-compliant Indian brand manufacturing (durable moat)
EBITDA margin guidance maintained 14–15% despite H1 16.3% — strategic hedge on H2 costs
H2 margin compression implied (~13% vs. H1 16.3%); SOC/DRAM volatility is primary risk
Competitive entry: 40+ STOC-certified brands; market share defense via price concessions possible
EYRA/NEXIVUE brand traction unproven; contribution not quantified
Export market entry 18–24 months out; nil near-term revenue visibility
Backward integration CapEx execution risk (₹650 Cr, 2–3 year timeline)
SOC and DRAM memory price volatility
HighManagement flagged this as the reason for H2 margin compression. If prices spike further or stay elevated, EBITDA could fall below 14% guidance. This is the single most material near-term risk.
Competitive intensity from new STOC entrants
Medium40+ new STOC-certified brands entering market. Though none from border nations yet certified, risk of share loss if entrants gain dealer/channel support. Could force price concessions or slow margin recovery in FY28–30.
Backward integration CapEx execution
Medium₹650 Cr CapEx over 2–3 years is substantial. Cost inflation or construction delays could push capacity online later than planned, limiting growth in FY28–29 and deferring margin benefits.
EYRA and NEXIVUE brand ramp uncertainty
MediumEYRA just hitting market (end-Nov). NEXIVUE contribution not quantified. If brands fail to gain traction, market share gains are all from CP PLUS; implies slower long-term TAM expansion.
Export market execution (18–24 month timeline)
MediumGeographies still undefined. If execution slips or initial volume is immaterial, growth narrative loses a key catalyst for FY28–29.
One-time fire loss signals operational concentration
LowKadapa fire (fully insured, ₹34.4 Cr loss) underscores facility dependency. Greater Noida expansion partially de-risks, but concentration remains until capacity is truly duplicated.
1 · H2 EBITDA margin delivery vs. guided 14–15%
The acid test. If Q3 or Q4 EBITDA margin falls below 13%, it signals cost headwinds faster than guided and resets the narrative downward. If margins hold 14–15%+, management has executed the hedge as planned. This is the highest-priority metric.
2 · EYRA and NEXIVUE contribution to Q3 revenue
Both brands need to show material contribution to validate the multi-brand strategy. If they remain immaterial, market share gains are all from CP PLUS, suggesting slower TAM expansion and limited runway.
3 · FII/DII flows and insider activity post-bulk deals
Mutual funds are accumulating (Motilal, Kotak), but Dixon sold ₹291 Cr on Nov 11 near ATH. Monitor Q3 shareholding pattern for trend confirmation. If insiders continue trimming near highs while funds add, that's a bearish divergence.
Aditya delivered a credible Q2 and raised FY27 guidance, but the market has already priced in the beat — the stock ran to all-time high of ₹4,618.8, then cooled 8.87% as the H2 margin compression story sank in. This is steady execution, not a step-change. Holders should track the pre-exceptional PAT run-rate (organic profit, stripping the fire loss) and watch whether H2 EBITDA margin stays true to the 14–15% guided range.
The number to anchor on: implied H2 EBITDA margin. If H1 was 16.3% and FY27 target is 14–15%, then H2 is ~12–13%. Every basis point of H2 margin delivery vs. that guide will signal whether management has the pricing power and cost control to defend share in an inflationary environment. That margin story is what resolves the bear debate next quarter.
Informational and educational content only. Not investment advice.